Ismaili: Free therapy for patients suffering from Sclerosis Multiple

Ismaili has announced that this Tuesday patients will no longer need to buy it but will receive it for free at our health institutions.

I've signed the first interferon- Beta 1a supply contract to be affected by Sclerosis Multiple. Since this therapy was no longer part of the essential list, many Kosovo families affected by this rare disease have been impoverished as a result of high expenditures.

From today, they won't need to buy it anymore but they'll get it free in our health institutions.

Moreover, Ocrelizumab's therapy is also in the process of buying. Very happy with the first effects of the new Esenscial Bars List. ♪Basing” wrote Ismaili on Facebook.